NVST Envista Holdings Corporation Cumulative Company Assets

Official company branding of Envista Holdings Corporation (NVST)

Envista Holdings (NVST) maintains its leadership in dentistry due to physician loyalty to its systems. Production relies on robotic lines equipped with machine vision, although scientists drive the innovations. The valuation of the company's financial assets captures the actual volume of resources, where 5621.30 becomes the new value of the indicator. Stable market positions allow the company to scale margins through the modernization of assembly lines.

Company Total Assets: Envista Holdings Corporation (NVST) for 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for Envista Holdings Corp (NVST)

- share price and expert price forecast:
Price envistaco.com|NVST - Price Target Chart
- market capitalization data:
Market Valuation Nobel Biocare|NVST - Enterprise Value
- company book value details:
Net Asset Value per Share Envista|NVST - Book Capitalization|Capitalization to Book Value Ratio envistaco.com|NVST - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Envista Holdings|NVST - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Nobel Biocare|NVST - Company Aggregate Debts|Debts to Book Capitalization Nobel Biocare|NVST - Company Long-Term Debt|Company Short-Term Debt Envista|Intermediate Coverage Ratio envistaco.com
- company profitability and valuation multiples indicators:
NVST - Net Profit
Fundamental valuation:Envista Holdings
Mass-produced product of Envista Holdings

The scale of Envista Holdings (NVST) operations is reflected in the dynamics of total assets, which is reverse-calculated via daily ROA to assess resource management efficiency. This indicator demonstrates the company's ability to capitalize on patent protection and physician loyalty, converting tangible assets into a sustainable competitive advantage, which allows investors to gauge the business's level of protection against market volatility.

Main competitors

ISRG: Aggregate Business Assets|Aggregate Company Assets Danaher|Cumulative Company Assets BD (BDX)|Company Total Assets STE|WST - Company Assets|Company Total Assets BAX (Baxter International)|MASI: Total Business Assets|Stevanato Group - Company Total Assets|Company Total Asset Base Teleflex Inc. TFX|MMSI: Company Total Assets|Cumulative Company Assets ICU Medical Inc.|XRAY (DENTSPLY SIRONA Inc.) - Company Total Assets|Company Total Assets lemaitre.com|Aggregate Company Assets AtriCure (ATRC)|Aggregate Company Assets STAA (STAAR Surgical Co.)|niagenbioscience.com - Cumulative Company Assets|Aggregate Asset Value ZIMV|AngioDynamics, Inc. - Company Total Assets|Company Total Asset Base cerus.com CERS|Teknova (TKNO) - Aggregate Company Assets|Total Business Assets MGRM|Aggregate Company Assets Sharps Technology Inc|InfuSystem Inc (INFU) - Company Total Asset Base|Cumulative Company Assets UTMD (Utah Medical Products)|Aggregate Business Assets KRMD|Aggregate Company Assets Nyxoah NYXH|Aggregate Asset Value MBOT|PDEX: Cumulative Company Assets|ZTEK - Company Total Assets|Elutia Inc. (ELUT) - Aggregate Company Assets|Cumulative Company Assets milestonescientific.com|NXGL (NEXGEL) - Company Total Assets|Company Assets Retractable Tech RVP|Aggregate Company Assets Harvard Bioscience (HBIO)|Femasys Corporation - Total Business Assets|Meihua Medical Technologies Co., Ltd. - Cumulative Company Assets|Aggregate Business Assets POAI (Predictive Oncology Inc)|CJMB - Aggregate Company Assets|Company Total Asset Base Atrion Corp. ATRI|NURO: Company Total Assets